Twitter Linkedin

Biopharma Excellence
News & Events
Resource Library
Careers
- Life at PharmaLex
- Current Opportunities
Training

Top Bar

MENUMENU

About UsAbout Us
Our Services
- Discovery / Non-clinical
  - - - Go to Discovery / Non-clinical section >>
  - - - Strategy and Consulting
        Integrated Product Development
        Market Access
        Scientific Advice
        Statistical Services
        Toxicology Services
- Clinical Development
  - - - Go to Clinical Development section >>
  - - - Strategy and Consulting
        Clinical Program Development
        Scientific Advice
        Statistical Services
      - Regulatory Affairs
        Clinical Trial Applications
        Global Procedure Management
        Health Authority / Agency Interaction
        Regulatory Operations
    - - Pharmacovigilance
        Clinical Trial Safety Support
        Pharmacovigilance Consulting
      - Quality
        GxP Services
        Interim / Contract QA
        Quality Management Systems
        Tech Transfer / Scale-up
- Authorization / Approval
  - - - Go to Authorization / Approval section >>
  - - - Strategy and Consulting
        Market Access
      - Regulatory Affairs
        CMC Services
        Global Procedure Management
        Health Authority / Agency Interaction
        Marketing and Labeling Activities
        Regulatory Operations
        Scientific, Regulatory and Technical Writing
        Statistical Services
    - - Pharmacovigilance
        EU QPPV / National QPPV
        Pharmacovigilance Consulting
      - Quality
        Commercialization Readiness
        Commissioning, Qualification, and Validation (CQV)
        GxP Services
        Interim / Contract QA
        PAI Readiness
- Post-approval / Maintenance
  - - - Go to Post-approval / Maintenance section >>
  - - - Strategy and Consulting
        Market Access
      - Regulatory Affairs
        CMC Services
        Global End-to-End Outsourcing
        Global Procedure Management
        Health Authority / Agency Interaction
        Marketing and Labeling Activities
        Mergers and Acquisitions (M&A) Transfers
        Regulatory Operations
        Toxicology Services
      - Pharmacovigilance
        EU QPPV / National QPPV
        ICSR (Individual Safety Case Report) Management
        Literature Monitoring & Screening
        Pharmacovigilance Quality & Compliance
        Signal Management
    - - Quality
        Commissioning, Qualification, and Validation (CQV)
        GxP Services
        Interim / Contract QA
        Quality Management Systems
      - Medical Affairs
        Healthcare Compliance and Medical Approval
- Program Management
  - - - Go to Program Management section >>
      - Program Management
        Global End-to-End Outsourcing
        Global Procedure Management
        Integrated Product Development
        Mergers and Acquisitions (M&A) Transfers
- Featured Expertise
  - - - Industry Expertise
        Biopharmaceuticals
        MedTech Services
    - - Service Expertise
        ATMP / Cell and Gene Therapy
        COVID-19 Support
        GxP Services
        Market Access
        Pharmacovigilance Consulting
        Post-Brexit Regulatory Support
        Statistical Services
      - SMARTPHLEX - technology-enabled services
Global ReachGlobal Reach
Contact usContact us
News & Events
Resource Library
Careers
- Life at PharmaLex
- Career Opportunities
Training

Home > Archives for 27th February 2018

Daily Archives: 27th February 2018

Top Tips for Deviation Writing

27th February 2018

Upcoming Webinars

October 27th, 2021

Using R Shiny for Bayesian Prior Determination and Clinical Trial Design

4:00 PM CET

Recent News

Development and Lifecycle Management of Software as a Medical Device
19th October 2021
How to achieve inspection readiness
18th October 2021
Pharmalex Launches Biopharma Excellence Brand, with Ex-MHRA Scientific Lead Dr. Christian K. Schneider at the Helm
13th October 2021
Recent changes in Australia for COVID-19 Rapid Antigen Self-Tests
30th September 2021
Defining and Regulating the Complex World of Software as a Medical Device
30th September 2021
TGA repeals mandatory Conformity Assessment Certification and audit requirements
27th September 2021

Categories

All News
Webinars
Events

Archive

Archive

Biopharma Excellence Website Image

PharmaLex Brings You Biopharma Excellence

Biopharma Excellence is a fusion of three scientific powerhouses, PharmaLex, ERA Consulting and Biopharma Excellence – all under the PharmaLex brand. This global team of scientific, regulatory and commercial professionals provide strategic product development and proactive regulatory services to developers of biopharmaceuticals, cell and gene therapies, monoclonal antibodies (MABs), vaccines and biosimilars.

USEFUL LINKS

Home
Contact us
Imprint
Data Protection
Terms and Conditions
Statistics and Data Science
MedTech Services

RECENT TWEETS

PharmaLex @PharmaLexGLOBAL·

The implementation of the new European #MDR (2017/745), now in place since May 2021 and #IVDR (2017/746) less than a year away, has proven to be a very challenging task for the whole sector.

Let’s have a look at the progress made over the past year.
https://www.pharmalex.com/update-on-notified-bodies-designation-under-mdr-ivdr/

COVID-19 NEWSLETTER SIGN UP

WHAT OUR CLIENTS SAY

What was especially important to me was their ability to get a team, with the right experience, together so quickly.

Mid-size Biotech
Head of Outsourcing

©2021 PharmaLex GmbH. All rights reserved.

ISO9001:2015 Logo

Please DO NOT send us event/conference information.
We will not respond and these will be deleted immediately.

Select your state:

Please tick this box to agree to our Privacy Policy

Please tick this box if you agree to periodic updates from PharmaLex.
You can unsubscribe at any time at data.protection@pharmalex.com

Please leave this field empty.

Click here to view our Privacy Policy.

Δ

#AskTheExpert #TogetherBEYONDCOVID19

Select your state:

Please tick this box to agree to our Privacy Policy

Please tick this box if you agree to periodic updates from PharmaLex.
You can unsubscribe at any time at data.protection@pharmalex.com

Please leave this field empty.

If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

Δ

#TogetherBEYONDCOVID19

We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for